Narrow your search

Library

EhB (1)

KU Leuven (1)

LUCA School of Arts (1)

Odisee (1)

Thomas More Kempen (1)

Thomas More Mechelen (1)

UCLouvain (1)

UCLL (1)

ULB (1)

ULiège (1)

More...

Resource type

book (1)


Language

English (1)


Year
From To Submit

2005 (1)

Listing 1 - 1 of 1
Sort by
Camptothecins in cancer therapy
Authors: ---
ISBN: 9781588290274 1588290271 9781592598663 9786610359509 1280359501 1592598668 1627038167 Year: 2005 Publisher: Totowa, N.J. : Humana Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Clinical interest in the camptothecins continues to expand even though this class of topoisomerase I inhibitors has been studied for almost 50 years, and two early generation members of the family have gained FDA approval. In Camptothecins in Cancer Therapy, leading clinicians and researchers critically review our current understanding of camptothecins, their shortcomings, and the possibilities for improving their clinical performance. The authors discuss new camptothecin analog development, drug delivery issues for optimizing their anticancer activity, and their potential use in a variety of different cancers. Additional chapters describe what is known about the biochemistry, the pharmacology, and the chemistry of the camptothecins, including the mechanism of topoisomerase and how camptothecins poison this enzyme, the use of animal models in defining the anticancer potential of camptothecins, and the question of camptothecin resistance. Authoritative and up-to-date, Camptothecins in Cancer Therapy provides a comprehensive summary of camptothecin research, as well as a much-needed guide to all the latest information on their optimal therapeutic applications.

Listing 1 - 1 of 1
Sort by